Advanced Filters
noise
Found 65,447 clinical trials
A Anthony Back

MDMA-Assisted Therapy for Pathological Narcissism

This open-label, proof-of-concept pilot study will assess the efficacy and safety of midomafetamine (MDMA) - assisted therapy (AT) for participants diagnosed with pathological narcissism. As all participants will be allocated to a single group assignment, there will be no blinding, randomization, or comparator treatment. Participants will have a screening visit, …

18 - 64 years of age All Phase N/A
C Carolyn Grove, Dr

A Trial of SHR-1139 in Healthy Volunteers

The purpose of this study is to assess safety, PK and immunogenicity profile of a single dose of SHR-1139 in healthy volunteers

18 - 55 years of age All Phase 1
A Amy Mundisev, RN, MSN, CNL

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

This pilot study uses [18F]F AraG PET imaging to evaluate the immunological response to checkpoint inhibitor therapy (CkIT) in patients with advanced NSCLC tumors. The study's main objectives are to quantify the change in [18F]F AraG PET signal before and while on CkIT therapy and to correlate this change in …

18 years of age All Phase 2
N Nicholas Madian, Ph.D.

Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort

Background The way the brain processes rewards and punishments may play a role in some disorders of the nervous system. People with chronic overlapping pain conditions (such as myalgic encephalomyelitis/chronic fatigue syndrome [ME/CFS]) may have heightened responses to unpleasant, punishing sensations. Some of these conditions may also cause heightened responses …

18 - 50 years of age All Phase N/A
B Brittany Koch

BHB & CAR-T for Lymphomas

The aim of this study is to assess the feasibility of β-hydroxybutyrate (BHB) supplementation in individuals who are receiving therapy for lymphoma with standard-of-care anti-CD19 CAR T-cells (CAR-T) to determine whether BHB supplementation is safe and tolerable in this patient population. Additionally, this study will determine whether BHB supplementation leads …

18 years of age All Phase N/A

Single vs. Dual Implant Fixation for Distal Femur Fractures in Older or Compromised Adults

The goal of this clinical trial is to assess the feasibility of conducting a larger study comparing single implant fixation (SIF) and dual implant fixation (DIF) for treating distal femur fractures (DFF) in older or compromised adults. It will also evaluate the safety and effectiveness of these treatments. The main …

18 - 100 years of age All Phase N/A
J Junlong Zhang, PHD

Effect of Sport Education on Physical Fitness and Learning Attitude Among Junior High School Students

Since the outbreak of COVID-19, students; sports environment and time have been severely compressed, which has had an unprecedented impact on their physical fitness and sports learning attitude. Therefore, it is urgent to adopt an effective teaching mode that aligns with curriculum reform to improve students; physical quality and learning …

13 - 15 years of age All Phase N/A
J Jenna Makarewicz, B.S.

Choline Dose Ranging in Postmenopausal Women

This study will use a randomized placebo-controlled trial to examine smaller doses of choline and whether a signal in the brain is detectable using fMRI. This study will examine if an even smaller doses of choline can show these similar brain activation and connectivity patterns to the 1650 mg dose. …

50 - 65 years of age Female Phase N/A
K Kristin W Sunde, MSc

Strengthening Hope After ICU Discharge

The goal of this clinical trial is to evaluate an interventional program that aims to strengthen hope in intensive care unit (ICU) patients in the rehabilitation phase. The main questions it aims to answer are: To develop and implement a follow-up service to strengthen hope in ICU patients, and to …

18 - 85 years of age All Phase N/A
Y Yanqing Ma, M.D & Ph.D

CD123-CD16-NK Cells Immunotherapy for AML

The goal of this clinical trial is to evaluate the effectiveness of CD123-CD16 bispecific antibody-modified NK cells in treating patients with CD123-positive relapsed or refractory Acute Myeloid Leukemia (RR AML). It will also assess the safety of this modified NK cell therapy. The main questions: Does the infusion of CD123-CD16 …

18 - 70 years of age All Phase 1

Simplify language using AI